Biomarkers in the pharmaceutical industry.
Director, Immunochemistry and Mass Spectrometry, Molecular Biomarkers and Diagnostics, Merck Research Laboratories, Rahway, NJ; omar.laterza@merck.com.
Omar F
OF
Laterza
Senior Vice President, Deputy to the President, Research & Translational Medicine, Sanofi, Paris, France;
Andrew
A
Plump
Senior Director, Clinical & Exploratory Pharmacology, Sanofi, Bridgewater, NJ;
Jeffrey E
JE
Ming
Group Vice President, Clinical Laboratory Sciences, Disposition, Safety and Animal Research, Sanofi, Framingham, MA;
Susan
S
Richards
Executive Director, Biomarker Technologies, Bristol-Myers Squibb Co., Lawrenceville, NJ;
Michael E Ransom
ME
Burczynski
Vice President and Head of Global Experimental Medicine, Takeda Pharmaceuticals, Cambridge, MA;
John A
JA
Wagner
Executive Director, Medical Sciences, Amgen, Thousand Oaks, CA.
Scott D
SD
Patterson
D015415:Biomarkers / Q000032:analysis*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000032:analysis*; D011786:Quality Control
D015415:Biomarkers; D004364:Pharmaceutical Preparations